🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Virginia

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Virginia

6 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Virginia.

Tèks ofisyèl etid la (Anglè)

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • VCU Massey Comprehensive Cancer Center, Richmond
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

  • Urology of Virginia ( Site 0125), Virginia Beach
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06833073

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Virginia Urology, Richmond
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • University of Virginia Comprehensive Cancer Center, Charlottesville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

  • Potamac Urology Center, Alexandria
Ap rekriteFaz 1/2
Laj 18 a 85 · Tout sèks · Mizajou Mar 27, 2026 · NCT06800963

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

  • University of Virginia, Charlottesville
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Dec 16, 2024 · NCT05790850

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.